You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people

  • Technology appraisal guidance
  • Reference number: TA300
  • Published:  27 November 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Appraisal committee members, guideline representatives and NICE project team
  • 7 Sources of evidence considered by the Committee

1 Recommendations

1.1

Peginterferon alfa in combination with ribavirin is recommended, within its marketing authorisation, as an option for treating chronic hepatitis C in children and young people.


Next page 2 Clinical need and practice Previous page Overview
Back to top